Agenus | AGEN - DEBITO

Prezzo Delle Azioni
4.15
Cambio Giornaliero
0.19 4.80%
Mensile
26.14%
Annuale
133.15%
Q2 Previsione
3.85




DEBITO Cambiamento Data
AbbVie USD 1000K 70.48B 2025-09
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Celldex Therapeutics USD 2.62M 410K 2025-09
CSL USD 11.96B 219M 2024-12
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Incyte USD 40.41M 855K 2025-12
Intrexon USD 0 13.82M 2024-06
J&J USD 45.8B 4.97B 2025-09
Jiangsu Hengrui CNY 91.43M 17.24M 2025-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 37.01M 238K 2025-09
Merck EUR 12.1B 2.7B 2025-09
Merck USD 41.37B 5.97B 2025-09
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Novartis USD 32.64B 1.37B 2025-06
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 60.85B 78M 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 40.45M 10.19M 2025-09